Gene · 917
Papers1,874
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,874
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CAR T cells for hematological malignancies. | J Clin Invest | 2024 | 38226627 | PubTator, text mining | PubMed |
| Single-Cell Sequencing Combined with Transcriptome Sequencing Constructs a Predictive Model of Key Genes in Multiple Sclerosis and Explores Molecular Mechanisms Related to Cellular Communication. | J Inflamm Res | 2024 | 38226354 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analyses of tumor microenvironment and molecular reprograming landscape of metastatic laryngeal squamous cell carcinoma. | Commun Biol | 2024 | 38191598 | PubTator, text mining | PubMed |
| Unraveling neoantigen-associated genes in bladder cancer: An in-depth analysis employing 101 machine learning algorithms. | Environ Toxicol | 2024 | 38189174 | PubTator, text mining | PubMed |
| M6A plays a potential role in carotid atherosclerosis by modulating immune cell modification and regulating aging-related genes. | Sci Rep | 2024 | 38168909 | PubTator, text mining | PubMed |
| T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors. | Nat Commun | 2024 | 38167722 | PubTator, text mining | PubMed |
| Toll-like receptor agonists as cancer vaccine adjuvants. | Hum Vaccin Immunother | 2024 | 38155525 | PubTator, text mining | PubMed |
| Genomic insights and prognostic significance of novel biomarkers in pancreatic ductal adenocarcinoma: A comprehensive analysis. | Biochem Biophys Rep | 2024 | 38107664 | PubTator, text mining | PubMed |
| Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia. | Biomed Pharmacother | 2024 | 38104416 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Reveals the Heterogeneity of the Immune Landscape of IDH-Wild-Type High-Grade Gliomas. | Cancer Immunol Res | 2024 | 38091354 | PubTator, text mining | PubMed |
| A high-throughput two-cell assay for interrogating inhibitory signaling pathways in T cells. | Life Sci Alliance | 2024 | 38073578 | PubTator, text mining | PubMed |
| Identification of driving genes of familial adenomatous polyposis by differential gene expression analysis and weighted gene co-expression network analysis. | Technol Health Care | 2024 | 38073344 | PubTator, text mining | PubMed |
| The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation. | Cell Mol Immunol | 2024 | 38062129 | PubTator, text mining | PubMed |
| Intratumor APOL3 delineates a distinctive immunogenic ferroptosis subset with prognosis prediction in colorectal cancer. | Cancer Sci | 2024 | 37986654 | PubTator, text mining | PubMed |
| Epigenetic profiles guide improved CRISPR/Cas9-mediated gene knockout in human T cells. | Nucleic Acids Res | 2024 | 37985205 | PubTator, text mining | PubMed |
| Suppressed transcript diversity and immune response in COVID-19 ICU patients: a longitudinal study. | Life Sci Alliance | 2024 | 37918965 | PubTator, text mining | PubMed |
| Multiomics Data Reveal the Important Role of ANXA2R in T Cell-mediated Rejection After Renal Transplantation. | Transplantation | 2024 | 37677931 | PubTator, text mining | PubMed |
| Differential Gene Expression of SARS-CoV-2 Positive Bronchoalveolar Lavages: A Case Series. | Pathobiology | 2024 | 37490884 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the evolution of immune molecules across multiple vertebrate species. | J Adv Res | 2024 | 36871615 | PubTator, text mining | PubMed |
| Simulating neuronal development: exploring potential mechanisms for central nervous system metastasis in acute lymphoblastic leukemia. | Front Oncol | 2023 | 38239636 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/917/papers?page=6